ECE2009 Poster Presentations Endocrine tumours and neoplasia (53 abstracts)
Serum chromogranin A assay in the biological diagnosis of pheochromocytomas and/or paragangliomas: results in 146 patients
Michele d’Herbomez 1 , Catherine Bauters 2 , Philippe Caron 3 , Christine Do Cao 2 , Pascal Pigny 4 , Emmanuelle Leteurtre 5 , Bruno Carnaille 6 & Jean-Louis Wémeau 2
1Department of Nuclear Medicine, CHRU, Lille, France; 2Clinic of Endocrinology, CHRU, Lille, France; 3Clinic of Endocrinology, CHRU, Toulouse, France; 4Department of Biochemistry, CHRU, Lille, France; 5Department of Pathology, CHRU, Lille, France; 6Department of Endocrine Surgery, CHRU, Lille, France.
The biological diagnosis of pheochromocytoma (P) and/or paraganglioma (Pgg) relies on the identification of excessive secretion of the metanephrines. Chomogranin A (CgA) is a general indicator of neuroendocrine tumours that is highly expressed in P and correlate with tumour mass and secretory activity. The CgA test could be indicated as a useful test in patients with false positive metanephrines results. The aim of our prospective bi-centre study, is to evaluate the performances of the CgA assay in the diagnosis of the P and Pgg according to the hereditary context and the localization of these tumours. One hundred forty six patients (67 females and 79 males) have a P and/or Pgg. All patients have had surgery and the diagnoses were confirmed by histological examinations. Thirsty eight patients (26%) have a hereditary disease.We used a radioimmunometric assay (Cis Bio-international, cut-off level to 120 ng/ml). The overall sensitivity of the CgA was equal to 92.7, 95.3% in a sporadic context and 84% in a hereditary context. The means CgA are significant different between the hereditary or sporadic diseases (P<0.01) as for the metanephrines concentrations. In patients with Pgg, (11 sporadic, 19 hereditary) the mean CgA was significant higher in the sporadic than in the hereditary Pgg (P<0.05). The means CgA in patients with sporadic P did not differ significantly from those of patients with sporadic Pgg. The means CgA appears also to be different regarding the genetic forms of P and Pgg.
In conclusion, CgA assay is a useful tool for the diagnosis of P and Pgg with a high sensitivity, better for sporadic than for hereditary diseases. CgA is a biochemical marker for the diagnosis of the P as for the majority of the Pgg with some variations according to the genetic context.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more